Dermatology Therapy

2004 Edition
| Editors: N. Levine, C. C. Levine

Ciclopirox

Reference work entry
DOI: https://doi.org/10.1007/3-540-29668-9_591
How to cite

Trade name(s)

Loprox; Penlac

Generic available

No

Drug class

Topical antifungal agent

Mechanism of action

Affects synthesis of fungal cell wall

Dosage form

0.77% cream, gel, lotion; 8% nail lacquer

Dermatologic indications and dosage

See table

Common side effects

Cutaneous: burning, itching, redness, swelling

Serious side effects

None

Drug interactions

None

Contraindications/precautions

Hypersensitivity to drug class or component

References

  1. Gupta AK, Baran R (2000) Ciclopirox nail lacquer solution 8% in the 21st century. Journal of the American Academy of Dermatology 43(4 Supplement):S96–102PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2004